Quick Answer
Galmed Pharmaceuticals Ltd. reported Net Income of -$10.31 million for fiscal year 2025.
Galmed Pharmaceuticals Ltd. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$10.31M | -37.1% |
| 2024 | -$7.52M | -8.8% |
| 2023 | -$6.91M | +61.3% |
| 2022 | -$17.87M | +45.0% |
| 2021 | -$32.47M | -12.8% |
| 2020 | -$28.77M | -40.6% |
| 2019 | -$20.46M | — |
- Galmed Pharmaceuticals Ltd. showed a decrease of -37.1% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Galmed Pharmaceuticals Ltd.’s net income has grown by 49.6% (from -$20.46 million to -$10.31 million).
- The most recent figure is from Galmed Pharmaceuticals Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: